Literature DB >> 31745346

Human and translational immunology in the third millennium: progress, challenges and opportunities.

Eynav Klechevsky1, Evangelos Andreakos2, Ioanna E Galani3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31745346     DOI： 10.1038/s41590-019-0543-6

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  1 in total

Review 1.  The potential of the microbiota to influence vaccine responses.

Authors:  David J Lynn; Bali Pulendran
Journal:  J Leukoc Biol       Date:  2017-12-28       Impact factor: 4.962
  1 in total
  2 in total

1.  Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer.

Authors:  Jiang Chen; Yangjie Liao; Rui Li; Mingjiang Luo; Guanlin Wu; Ruirong Tan; Zhihong Xiao
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 2.  Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game.

Authors:  Jean-Louis Palgen; Yanis Feraoun; Gaëlle Dzangué-Tchoupou; Candie Joly; Frédéric Martinon; Roger Le Grand; Anne-Sophie Beignon
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.